CEACAM5抗體 返回列表頁(yè)

CEACAM5抗體

抗原
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5)
別名 CEACAM5, CEA, CEACAM, RGD1311281, CD66e, 1600029H12Rik, Psg30
適用
其他選擇 Human
Human(310),Murine (9),Rat ((Rattus)) (2)
宿主
其他選擇 Rabbit
Mouse(215),Rabbit (93),Goat (8),Sheep (3),Mouse (Murine) (2),Chicken (1)
克隆類(lèi)型
多克隆
標(biāo)記
其他選擇 非結(jié)合性
Biotin(10),FITC (8),PE (6),HRP (4)
應(yīng)用范圍
其他選擇 Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
ELISA(113),Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (112),Western Blotting (WB) (107),Immunohistochemistry (Frozen Sections) (IHC (fro)) (68),Immunohistochemistry (IHC) (64),Flow Cytometry (FACS) (50),Immunoprecipitation (IP) (33),Immunofluorescence (IF) (23),Immunohistochemistry (Frozen Paraffin-embedded Sections) (IHC (frpe)) (21),Immunocytochemistry (ICC) (19),Enzyme Immunoassay (EIA) (16),Radioimmunoassay (RIA) (13),Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (10),Immunohistochemistry (Acetone-fixed) (IHC (af)) (9),Protein Assay (PrA) (6),Cell-ELISA (cELISA) (2),Immunohistochemistry (Formalin-fixed Sections) (IHC (f)) (2),Lateral Flow (LF) (2),Dot Blot (DB) (1),ELISA (Capture) (1),ELISA (Detection) (1),Labeling (Lbl) (1)
規(guī)格 0.5 mL
發(fā)貨至 中國(guó) (更改)
發(fā)貨時(shí)間 24至29個(gè)工作日

CEACAM5抗體

產(chǎn)品細(xì)節(jié)

圖像 貯存及處理 使用細(xì)節(jié) 目標(biāo)詳細(xì)情況 回頁(yè)首

產(chǎn)品細(xì)節(jié)

顯示 隱藏
免疫原 Purified human CEA
亞型 IgG
產(chǎn)品特性 Cellular Localization: Cytoplasm, lumenal membrane
純化方法 Immunogen Affinity Purified

目標(biāo)詳細(xì)情況

圖像 貯存及處理 使用細(xì)節(jié) 回頁(yè)首

目標(biāo)詳細(xì)情況

顯示 隱藏
別名 CEA/CD66e
背景 Carcinoembryonic antigen (CEA) is synthesized during development in the fetal gut, and is re- expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is reportedly useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60-70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).
分子量 84 kDa
基因ID 1048

使用細(xì)節(jié)

圖像 貯存及處理 目標(biāo)詳細(xì)情況 回頁(yè)首

使用細(xì)節(jié)

顯示 隱藏
應(yīng)用備注 IHC Dilution: 1:200
說(shuō)明

Positive Control:
IHC (p): Colon carcinomas

實(shí)驗(yàn)流程 IHC Procedure: Specimen
Preparation: Formalin-fixed, paraffin-embedded tissues are suitable for use with this primary antibody.
Deparaffinization: Deparaffinize slides using xylene or xylene alternative and graded alcohols.
Antibody Dilution: If using the concentrate format of this product, dilute the antibody 1:200. The dilutions are estimates, actual results may differ because of variability in methods and protocols.
Antigen Retrieval: No special pretreatment necessary.
Primary Antibody Incubation: Incubate for 10 minutes at RT.
Slide Washing: Slides must be washed in between steps. Rinse slides with PBS/0.05 % Tween.
Visualization: Detect the antibody as instructed by the instructions provided with the visualization system.
限制 For Research Use only

貯存及處理

圖像 使用細(xì)節(jié) 目標(biāo)詳細(xì)情況 回頁(yè)首

貯存及處理

顯示 隱藏
狀態(tài) Liquid
緩沖液 immunogen affinity purified rabbit polyclonal antibody in PBS/1 % BSA buffer pH 7.6 with less than 0.1 % sodium azide.
儲(chǔ)存液 Sodium azide
注意事項(xiàng) 1. Avoid contact of reagents with eyes and mucous membranes. If reagents come into contact with sensitive areas, wash with copious amounts of water.
2. This product is harmful if swallowed.
3. Consult local or state authorities with regard to recommended method of disposal.
4. Avoid microbial contamination of reagents.
This product contains Sodium AzideTM: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
注意事項(xiàng) Do not freeze. The user must validate any other storage conditions. When properly stored, the reagent is stable to the date indicated on the label. Do not use the reagent beyond the expiration date. There are no definitive signs to indicate instability of this product, therefore, positive and negative controls should be tested simultaneously with unknown specimens.
儲(chǔ)存條件 4 °Cxy-12132R ASIC3酸敏感離子通道蛋白3抗體
xy-12137R Aspartate beta hydroxylase天門(mén)冬氨酸β羥化酶抗體
xy-10014R AVPR2精氨酸加壓素受體2抗體
xy-7119R ARP3細(xì)胞骨架肌動(dòng)蛋白樣蛋白3抗體
xy-6322R Annexin A8膜粘連蛋白8抗體
xy-6786R Aquaporin 8水通道蛋白8抗體
xy-9399R ANKRD40錨蛋白重復(fù)結(jié)構(gòu)域蛋白40抗體
xy-1252R API5凋亡抑制因子5抗體
xy-1253R AQP3水通道蛋白-3抗體
xy-1254R APOD載脂蛋白D抗體
xy-7641R ACSM3丁?；o酶A合成酶3抗體
xy-7643R ARTS1脂肪細(xì)胞源性亮氨酸氨基肽酶抗體（血管內(nèi)皮細(xì)胞生長(zhǎng)因子誘導(dǎo)蛋白）
xy-7655R AIFM2線(xiàn)粒體凋亡誘導(dǎo)因子2抗體
xy-1230R ABL2ABL2蛋白抗體
xy-0439R ACE血管緊張素轉(zhuǎn)換酶ACE1抗體
xy-1004R ACE2血管緊張素轉(zhuǎn)換酶2抗體
xy-0120R AcinusAcinus抗體
xy-1227R Ack1醋酸激酶1抗體
xy-0443R ACTH (1-39)促腎上腺皮質(zhì)激素(1-39)抗體
xy-0442R ACTH (18-39)促腎上腺皮質(zhì)激素ACTH(18-39)抗體
xy-0004R ACTH (7-23)促腎上腺皮質(zhì)激素ACTH (7-23)抗體
xy-0039R ADNP活性依賴(lài)的神經(jīng)保護(hù)肽抗體
xy-6852R Alpha 1 Acid Glycoproteinα1酸性糖蛋白1/類(lèi)粘蛋白1抗體
xy-7565R Alpha 1 acid glycoprotein 2α1酸性糖蛋白2抗體（類(lèi)粘蛋白2）
xy-4610R phospho-AQP2(Ser264+261)磷酸化水通道蛋白2抗體
xy-1907R ATTY細(xì)胞酪氨酸轉(zhuǎn)氨酶抗體
xy-1930R Vasopressin抗利尿激素/血管升壓素/加壓素/血管加壓素抗體
xy-1960R ABCF1ATP結(jié)合盒蛋白家族GCN20F家族1抗體
xy-2405R AKR1B1醛糖還原酶抗體
xy-0945R Serum albumin人血清白蛋白抗體
xy-0935R Anthrax炭疽菌抗體（采用活疫苗制備）
xy-1531R ATF4活化轉(zhuǎn)錄因子4抗體
xy-0299R Adenylate Kinase 1腺苷酸激酶-1抗體
xy-1571R F-Actin纖維狀肌動(dòng)蛋白抗體